Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis

Journal of Nuclear Medicine

Volumn 43, Issue 10, 2002, Pages 1359-1365

  Post, Anneke M ^a   Katsikis, Peter D ^a   Tait, Jonathan F ^a   Geaghan, Sharon M ^a   Strauss, H William ^a   Blankenberg, Francis G ^a  

^a NONE   (United States)

Author keywords

Annexin V; Apoptosis; Radionuclide; Rheumatoid arthritis

Indexed keywords

BOVINE SERUM ALBUMIN; COLLAGEN; LIPOCORTIN 5; METHYLPREDNISOLONE; RADIOISOTOPE; STEROID; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTORADIOGRAPHY; BONE; CARTILAGE; CELL DEATH; CONTROLLED STUDY; DISEASE SEVERITY; FOOT PAD; IMAGING; IMMUNIZATION; ISOTOPE LABELING; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; STEROID THERAPY; SYNOVITIS; T LYMPHOCYTE;

ANIMALS; ANNEXIN A5; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; COLLAGEN; MALE; METHYLPREDNISOLONE; MICE; MICE, INBRED DBA; SERUM ALBUMIN, RADIO-IODINATED; TECHNETIUM;

EID: 0036787658     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol. 2000;27:1386-1389.
2. Haagsma CJ, Blom HJ, van Riel PL. et al. Influence of sulphasalazine, methotrexate. and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58:79-84.
3. Hawley DJ, Wolfe F, Pincus T. Use of combination therapy in the routine care of patients with rheumatoid arthritis: physician and patient surveys. Clin Exp Rheumatol. 1999;17(6 suppl 18):S78-S82.
4. Elliot MJ, Maini RN, Feldmann M. et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor. Arthritis Rheum. 1993;36:1681-1690.
5. Bresnihan B, Alvaro-Gracia JM. Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998;41:2196-2204.
6. Lassere MN, van der Heijde D, Johnson KR, Boers M, Edmonds J. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials. Rheumatology. 2001;28:892-903.
7. Strand V, Lassere M, van der Heijde D, Johnson K, Boers M. Recent rheumatoid arthritis clinical trials using radiographic endpoints: updated research agenda. Rheumatology. 2001;28:887-889.
8. Wilson C, Tiwana H, Ebringer A. Molecular mimicry between HLA-DR alleles associated with rheumatoid arthritis and Proteus mirabilis as the aetiological basis for autoimmunity. Microbes Infect. 2000;2:1489-1496.
9. Hyrich KL, Inman RD. Infectious agents in chronic rheumatic diseases. Curr Opin Rheumatol. 2001;13:300-304.
10. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest. 1995;96:1631-1638.
11. Ceponis A, Hietanen J. Tamulaitiene M, Partsch G. Patiala H. Konttinen YT. A comparative quantitative morphometric study of cell apoptosis in synovial membranes in psoriatic, reactive and rheumatoid arthritis. Rheumatology. 1999;38:431-440.
12. Blankenberg, FG, Katsikis Katsilds PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA. 1998;95:6349-6354.
13. Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation. 1995;92:3113-3121.
14. van Heerde WL, de Groot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin V. Thromb Haemost. 1995;73:172-179.
15. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger CPM. A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 1995;184:39-51.
16. van den Eijnde SM, Luijsterburg AJM, Boshart L, et al. In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastrueture. Cytommetry. 1997;29:313-320.
17. Li X, Traganos F, Melamed MR, Darzynkiewicz Z. Single-step procedure for labeling DNA strand breaks with fluorescein- or BODIPY-conjugated deoxynucteotides: detection of apoptosis and bromodeoxyuridine incorporation. Cytometry. 1995;20:172-180.
18. Williamson P, Schlegel RA. Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. Mol Membr Biol. 1994;11:199-216.
19. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121-1132.
20. Martin SJ, Reutelingsperger CPM, McGahon AJ. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 Abl. J Exp Med. 1995;182:1545-1556.
21. Bennett MR, Gibson DF, Schwartz SM, Tait JF. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res. 1995;77:1136-1142.
22. Tait JF, Smith C, Wood BL. Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V. Blood Cells Mol Dis. 1999;25:271-278.
23. Naito M, Nagashima K, Mashima T, Tsuruo T. Phosphatidylserine externalization is a downstream event of interleukin-1β-converting enzyme family protease activation during apoptosis. Blood. 1997;89:2060-2066.
24. Vriens PW, Blankenberg FG, Stoot JH, et al. The use of 99m technetium labeled annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg. 1998;116:844-853.
25. Ogura Y, Krams SM, Martinez OM, et al. Radiolabeled annexin Vimaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology. 2000;214:795-800.
26. Blankenberg FG, Robbins RC, Stoot JH, et al. Radionuclide imaging of acute lung transplant rejection with annexin V. Chest. 2000;117:834-840.
27. Guide for the Care and Use of Laboratory Animals. Washington, DC: Government Printing Office; 1985. NIH publication 86-23.
28. Walmsley M, Katsikis PD, Abney E, et al. Interleukin-10 inhibition of the progression of established collagen induced arthritis. Arthritis Rheum. 1996;39:495-503.
29. Wood BL, Gibson DF. Tait JF. Increased phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
30. 99mTc] tricine: a useful precursor complex for the radiolabeling of hydrazinonicofinate protein conjugates. Bioconjug Chemistry. 1995;6:635-638.
31. 99mTc annexin V. J Nucl Med. 1999;40:184-191.
32. Zenmyo M, Komiya S, Kawabata R, Sasaguri Y, Inoue A, Morimatsu M. Morphological and biochemical evidence for apoptosis in the terminal hypertrophic chondrocytes of the growth plate. J Pathol. 1996;80:430-433.
33. Bronckers ALJJ, Goei W, van Heerde WL, Dumont EAWJ, Reutelingsperger CPM. van den Eijnde SM. Phagocytosis of dying chondrocytes by osteoclasts in the mouse growth plate as demonstrated by annexin-V labeling. Cell Tissue Res. 2000;301:267-272.
34. Morita I, Matsuno H, Sakai K, et al. Time course of apoptosis in collagen-induced arthritis, Int J Tissue React.998;20:37-43.
35. Eguchi K. Apoptosis in autoimmune diseases. Intern Med. 2001;40:275-284.
36. Matsumoto S, Mulier-Ladner U, Gay RE, Nishioka K, Gay S. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovialm fibroblasts. J Rheumatol. 1996;23:1345-1352.
37. Kim HA, Song YW. Apoptotic chondrocyte death in rheumatoid arthritis. Arthritis Rheum. 1999;42:1528-1537.
38. Jones ST, Denton J, Holt PJ, Freemont AJ. Possible clearance of effete polymorphonuclear leucocytes from synovial fluid by cytophagocytic mononuclear cells: implications for pathogenesis and chronicity in inflammatory arthritis. Ann Rheum Dis. 1993;52:121-126.